Predicting the rate of cognitive decline in aging and early Alzheimer disease

Neurology

Volumn 63, Issue 1, 2004, Pages 108-114

  Adak, S ^a   Illouz, K ^a   Gorman, W ^a   Tandon, R ^a   Zimmerman, E A ^b   Guariglia, R ^c   Moore, M M ^c   Kaye, J A ^c  

^a GE GLOBAL RESEARCH   (India)

^b ALBANY MEDICAL COLLEGE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CLINICAL DEMENTIA RATING SCALE; COGNITIVE DEFECT; DISEASE COURSE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE;

EID: 3242661645     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000132520.69612.AB     Document Type: Article

References (38)

1. Kraemer HC, Tinklenberg J, Yesavage JA. "How far" vs "how fast" in Alzheimer's disease. The question revisited. Arch Neurol 1994;51:275-279.
2. Stern Y, Tang MX, Albert MS, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA 1997;227:806-812.
3. Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B. A family intervention to delay nursing home placement of patients with Alzheimer's disease. A randomized controlled trial. JAMA 1996;276:1725-1731.
4. Gelb DJ. Measurement of progression in Alzheimer's disease: a clinician's perspective. Stat Med 2000;19:1393-1400.
5. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
6. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
8. Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch Neurol 2001;58:449-454.
9. Howieson DB, Holm LA, Kaye JA, Oken BS, Howieson J. Neurologic function in the optimally healthy oldest old. Neuropsychological evaluation. Neurology 1993;43:1882-1886.
10. Fillenbaum GG, Smyer MA. The development, validity and reliability of the OARS Multidimensional Functional Assessment Questionnaire. J Gerontol 1981;36:428-434.
11. Kiernan RJ, Mueller J, Langston JW, Van Dyke C. The Neurobehavioral Cognitive Status Examinations: a brief but quantitative approach to cognitive assessment. Ann Intern Med 1987;107:481-485.
12. Marquis S, Moore MM, Howieson DB, et al. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 2002;59:601-606.
13. Kaye JA, Swihart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997;48:1297-1304.
14. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied linear statistical models. 4th ed. Chicago: Irwin, 1996.
15. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
16. Cook NR, Ware JH. Design and analysis methods for longitudinal research. Annu Rev Public Health 1983;4:1-23.
17. Han L, Cole M, Bellavance F, McCusker J, Primeau F. Tracking cognitive decline in Alzheimer's disease using the Mini-Mental State Examination: a meta-analysis. Int Psychogeriatr 2000;12:231-247.
18. Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. Modelling Mini Mental State Examination changes in Alzheimer's disease. Stat Med 2000;19:1607-1616.
19. Milliken JK, Edland SD. Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note. Stat Med 2000;19:1617-1629.
20. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini Mental State Examination by age and education level. JAMA 1993;269:2386-2391.
21. Busing FMTA, Meijer E, Van der Leeden R. MLA-software for multilevel analysis of data with two levels. User's guide for version 1.0b. PRM 94-01, Lieden, the Netherlands.
22. De Leeuw J, Kraft IGG. Questioning multilevel models. UCLA statistics series no 143. Los Angeles: UCLA.
23. Lucca U, Comelli M, Tettamanti M, Tiraboschi P, Spagnoli A. Rate of progression and prognostic factors in Alzheimer's disease: a prospective study. J Am Geriatr Soc 1993;41:45-49.
24. Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB. Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. J Gerontol A: Biol Sci Med Sci 1995;50: M49-M55.
25. Morris JC, Edland S, Clark C, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993;43:2457-2465.
26. Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 2002;59:1034-1041.
27. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010.
28. Lautenschlager NT, Cupples LA, Rao VS, et al. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology 1996;46:641-650.
29. Farrer LA, Cupples LA, van Duijn CM, Connor-Lacke L, Kiely DK, Growdon JH. Rate of progression of Alzheimer's disease is associated with genetic risk. Arch Neurol 1995;52:918-923.
30. Payami H, Grimslid H, Oken B, et al. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet 1997;60:948-956.
31. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-1403.
32. Convit A, de Asis J, de Leon MJ, Tarshish CY, De Santi S, Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 2000;21:19-26.
33. Dickerson BC, Goncharova I, Sullivan MP, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 2001;22:747-754.
34. Killiany RJ, Hyman BT, Gomez-Isla T, et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002;58:1188-1196.
35. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341-355.
36. Wolf H, Ecke GM, Bettin S, Dietrich J, Gertz HJ. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry 2000;15:803-812.
37. DeCarli C. The role of neuroimaging in dementia. Clin Geriatr Med 2001;17:255-279.
38. Mueller EA, Moore MM, Kerr DC, et al. Brain volume preserved in healthy elderly through the eleventh decade. Neurology 1998;51:1551-1562.